Tomoyoshi Kondo

Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease

Makio Mogi, Akifumi Togari, Tomoyoshi Kondo et al. · Neuroscience Letters · 1999 · 394 citations

Life Sciences, Neurobiology, Neuroscience +16

p53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain

Makio Mogi, Tomoyoshi Kondo, Yoshikuni Mizuno et al. · Neuroscience Letters · 2006 · 241 citations

Life Sciences, Neurology, Neuroscience +16

Adenosine A_2A receptor antagonist istradefylline reduces daily OFF time in Parkinson's disease

Yoshikuni Mizuno, Tomoyoshi Kondo · Movement Disorders · 2013 · 219 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Clinical efficacy of istradefylline (KW‐6002) in Parkinson's disease: A randomized, controlled study

Yoshikuni Mizuno, Kazuko Hasegawa, Tomoyoshi Kondo et al. · Movement Disorders · 2010 · 189 citations

Medicine, Pharmacology, Pharmacotherapy +14

Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis

Takayuki Ozawa, Masashi Tanaka, Shin-ichiro Ikebe et al. · Biochemical and Biophysical Research Communications · 1990 · 187 citations

Life Sciences, Genetics, Molecular Genetics +17